SCHEMBL2498460

SCHEMBL2498460

CC[C@H](c1cccc(O)c1)C(C)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.57
SLC22A1 O15245 1/20 0.57
LMNA P02545 5/20 0.50
HIF1A Q16665 4/20 0.50
KDM4E B2RXH2 2/20 0.50
KYNU Q16719 1/20 0.48
ADRA1A P35348 3/20 0.44
ADRB1 P08588 2/20 0.44
MIF P14174 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2B P41595 1/20 0.44
GALR3 O60755 1/20 0.43
HKDC1 Q2TB90 1/20 0.42
DRD1 P21728 2/20 0.41
DRD3 P35462 2/20 0.41
SLC6A3 Q01959 2/20 0.41
ADRB2 P07550 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRB3 P13945 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13731382 1.00 OPRM1 (0.57) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL13731381 1.00 OPRM1 (0.57) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL2501603 1.00 OPRM1 (0.57) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL2495279 0.88 HIF1A (0.48) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL2503017 0.88 HIF1A (0.48) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL13730273 0.86 OPRM1 (0.56) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL19305061 0.86 OPRM1 (0.56) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL2494839 0.85 HIF1A (0.46) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL2497747 0.85 HIF1A (0.46) OPRM1SLC22A1LMNAHIF1AKDM4E
SCHEMBL27810362 0.85 HIF1A (0.46) OPRM1SLC22A1LMNAHIF1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030354-B2 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes AMGEN INC. (US) 2011-10-04 US disclosed